Background: SARS-CoV-2 is an RNA virus causing COVID-19. The clinical characteristics and epidemiology of COVID-19 have been extensively investigated, however, only one study so far focused on the patient's nasopharynx microbiota. In this study we investigated the nasopharynx microbial community of patients that developed different severity levels of COVID-19.
View Article and Find Full Text PDFThe EUCAST EDef 9.3.2 procedure recommends visual readings of azole and amphotericin B MICs against spp.
View Article and Find Full Text PDFEnferm Infecc Microbiol Clin
May 2014
Introduction: To describe the spectrum of infections caused by Rothia mucilaginosa.
Methods: Retrospective study of 20 cases diagnosed with R. mucilaginosa from 2009 to 2012.